Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Mar 13, 2024
Open Peer Review Period: Mar 15, 2024 - May 10, 2024
Date Accepted: Jun 12, 2024
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Web-Based Application for Reducing Methamphetamine Use Among Aboriginal and Torres Strait Islander People: Randomized Waitlist Controlled Trial

Reilly R, McKetin R, Barzi F, Degan T, Ezard N, Conigrave K, Butt J, Roe Y, Wand H, Quinn B, Longbottom W, Treloar C, Dunlop A, Ward J

Web-Based Application for Reducing Methamphetamine Use Among Aboriginal and Torres Strait Islander People: Randomized Waitlist Controlled Trial

J Med Internet Res 2025;27:e58341

DOI: 10.2196/58341

PMID: 40053754

PMCID: 11909485

A web-based application for reducing methamphetamine use amongst Aboriginal and Torres Strait Islander people: A wait-list control randomised trial.

  • Rachel Reilly; 
  • Rebecca McKetin; 
  • Federica Barzi; 
  • Tayla Degan; 
  • Nadine Ezard; 
  • Kate Conigrave; 
  • Julia Butt; 
  • Yvette Roe; 
  • Handan Wand; 
  • Brendan Quinn; 
  • Wade Longbottom; 
  • Carla Treloar; 
  • Adrian Dunlop; 
  • James Ward

ABSTRACT

Background:

Digital interventions can help to overcome barriers to care including stigma, geographical distance and a lack of culturally appropriate treatment options. We Can Do This was a web-app designed with input from cultural advisors and end-users to support Aboriginal and Torres Strait Islander people seeking to stop or reduce their use of methamphetamine and increase psychosocial wellbeing.

Objective:

We sought to evaluate the effectiveness of the web-app via a wait-list control, randomised trial

Methods:

Aboriginal and Torres Strait Islander people aged 16 or over who self-identified as having used methamphetamine weekly for the past three months were invited to participate online. Following a baseline survey, participants were randomised to either the intervention group, who could access the web-app for six weeks, or the control group, who received harm-minimisation material. Participants repeated the survey at one, two and three months post-baseline. We hypothesized that the intervention group would have significantly reduced frequency of use at three-month follow-up. Secondary outcomes included help-seeking, psychosocial distress and days spent out of usual role due to methamphetamine use.

Results:

Participants at baseline were 210 Aboriginal and/or Torres Strait Islander men and women aged 16 or over. Methamphetamine use declined significantly in all participants who completed three-month follow-up, however there were no significant differences between intervention and control groups on the primary or secondary outcomes.

Conclusions:

Drop out and a lack of sustained engagement hindered our ability to evaluate the effectiveness of the web-app. Nonetheless, the trial gleaned some useful lessons relating to recruitment and engagement in web-apps. Clinical Trial: Australian New Zealand Clinical Trials Registry ACTRN12619000134123p; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=376088&isReview=true


 Citation

Please cite as:

Reilly R, McKetin R, Barzi F, Degan T, Ezard N, Conigrave K, Butt J, Roe Y, Wand H, Quinn B, Longbottom W, Treloar C, Dunlop A, Ward J

Web-Based Application for Reducing Methamphetamine Use Among Aboriginal and Torres Strait Islander People: Randomized Waitlist Controlled Trial

J Med Internet Res 2025;27:e58341

DOI: 10.2196/58341

PMID: 40053754

PMCID: 11909485

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.